Crystal structures of murine angiogenin-2 and -3 - Probing 'structure - Function' relationships amongst angiogenin homologues

FEBS Journal

Volumn 280, Issue 1, 2013, Pages 302-318

  Iyer, Shalini ^a   Holloway, Daniel E ^a   Acharya, K Ravi ^a  

^a University of Bath   (United Kingdom)

Author keywords

angiogenin; crystal structure; enzyme mechanism; metal ion binding; ribonuclease A

Indexed keywords

ANGIOGENIN; ANGIOTENSIN II; ANGIOTENSIN III; RIBONUCLEASE A; RIBONUCLEOTIDE; ZINC ION;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME SUBSTRATE; HUMAN; MOLECULAR INTERACTION; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; STRUCTURAL HOMOLOGY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; CATALYTIC DOMAIN; CRYSTALLOGRAPHY, X-RAY; HUMANS; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR LOCALIZATION SIGNALS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, SECONDARY; RIBONUCLEASE, PANCREATIC; RIBONUCLEASES; RNA CLEAVAGE; RNA, TRANSFER; STRUCTURAL HOMOLOGY, PROTEIN; SULFATES; ZINC;

BOVINAE; MURINAE;

EID: 84872046419     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12071     Document Type: Article

References (78)

1. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, &, Vallee BL, (1985) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24, 5480-5486.
2. Acharya KR, Shapiro R, Allen SC, Riordan JF, &, Vallee BL, (1994) Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease. Proc Natl Acad Sci USA 91, 2915-2919.
3. Wlodawer A, Svensson LA, Sjölin L, &, Gilliland GL, (1988) Structure of phosphate-free ribonuclease A refined at 1.26 Å. Biochemistry 27, 2705-2717.
4. Shapiro R, Fox EA, &, Riordan JF, (1989) Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis. Biochemistry 28, 1726-1732.
5. Shapiro R, &, Vallee BL, (1989) Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis. Biochemistry 28, 7401-7408.
6. Olson KA, Fett JW, French TC, Key ME, &, Vallee BL, (1995) Angiogenin antagonists prevent tumor growth in vivo. Proc Natl Acad Sci USA 92, 442-446.
7. Olson KA, Byers HR, Key ME, &, Fett JW, (2001) Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin. Clin Cancer Res 7, 3598-3605.
8. Olson KA, Byers HR, Key ME, &, Fett JW, (2002) Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody. Int J Cancer 98, 923-929.
9. Kao RY, Jenkins JL, Olson KA, Key ME, Fett JW, &, Shapiro R, (2002) A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity. Proc Natl Acad Sci USA 99, 10066-10071.
10. Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, Patterson V, Swingler R, Kieran D, Prehn J, et al,. (2006) ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet 38, 411-413.
11. Subramanian V, &, Feng Y, (2007) A new role for angiogenin in neurite growth and pathfinding: implications for amyotrophic lateral sclerosis. Hum Mol Genet 16, 1445-1453.
12. van Es MA, Schelhaas HJ, van Vught PW, Ticozzi N, Andersen PM, Groen EJ, Schulte C, Blauw HM, Koppers M, Diekstra FP, et al,. (2011) Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol 70, 964-973.
13. Steidinger TU, Standaert DG, &, Yacoubian TA, (2011) A neuroprotective role for angiogenin in models of Parkinson's disease. J Neurochem 116, 334-341.
14. Wu D, Yu W, Kishikawa H, Folkerth RD, Iafrate AJ, Shen Y, Xin W, Sims K, &, Hu GF, (2007) Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol 62, 609-617.
15. Crabtree B, Thiyagarajan N, Prior SH, Wilson P, Iyer S, Ferns T, Shapiro R, Brew K, Subramanian V, &, Acharya KR, (2007) Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis. Biochemistry 46, 11810-11818.
16. Subramanian V, Crabtree B, &, Acharya KR, (2008) Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. Hum Mol Genet 17, 130-149.
17. Thiyagarajan N, Ferguson R, Subramanian V, &, Acharya KR, (2012) Structural and molecular insights into the mechanism of action of human angiogenin-ALS variants in neurons. Nat Commun 3, 1121.
18. Shapiro R, Strydom DJ, Olson KA, &, Vallee BL, (1987) Isolation of angiogenin from normal human plasma. Biochemistry 26, 5141-5146.
19. Rybak SM, Fett JW, Yao QZ, &, Vallee BL, (1987) Angiogenin mRNA in human tumor and normal cells. Biochem Biophys Res Commun 146, 1240-1248.
20. Moenner M, Gusse M, Hatzi E, &, Badet J, (1994) The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis. Eur J Biochem 226, 483-490.
21. Kishimoto K, Liu S, Tsuji T, Olson KA, &, Hu GF, (2005) Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 24, 445-456.
22. Lee FS, &, Vallee BL, (1989) Binding of placental ribonuclease inhibitor to the active site of angiogenin. Biochemistry 28, 3556-3561.
23. Papageorgiou AC, Shapiro R, &, Acharya KR, (1997) Molecular recognition of human angiogenin by placental ribonuclease inhibitor-an X-ray crystallographic study at 2.0 Å resolution. EMBO J 16, 5162-5177.
24. Chen CZ, &, Shapiro R, (1999) Superadditive and subadditive effects of "hot spot" mutations within the interfaces of placental ribonuclease inhibitor with angiogenin and ribonuclease A. Biochemistry 38, 9273-9285.
25. Shapiro R, Ruiz-Gutierrez M, &, Chen CZ, (2000) Analysis of the interactions of human ribonuclease inhibitor with angiogenin and ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "hot spot". J Mol Biol 302, 497-519.
26. Dickson KA, Kang DK, Kwon YS, Kim JC, Leland PA, Kim BM, Chang SI, &, Raines RT, (2009) Ribonuclease inhibitor regulates neovascularization by human angiogenin. Biochemistry 48, 3804-3806.
27. Bond MD, &, Vallee BL, (1990) Isolation and sequencing of mouse angiogenin DNA. Biochem Biophys Res Commun 171, 988-995.
28. Brown WE, Nobile V, Subramanian V, &, Shapiro R, (1995) The mouse angiogenin gene family: structures of an angiogenin-related protein gene and two pseudogenes. Genomics 29, 200-206.
29. Fu X, &, Kamps MP, (1997) E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Mol Cell Biol 17, 1503-1512.
30. Strydom DJ, (1998) The angiogenins. Cell Mol Life Sci 54, 811-824.
31. Cho S, Beintema JJ, &, Zhang J, (2005) The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories. Genomics 85, 208-220.
32. Codoñer FM, Alfonso-Loeches S, &, Fares MA, (2010) Mutational dynamics of murine angiogenin duplicates. BMC Evol Biol 10, 310-314.
33. Nobile V, Vallee BL, &, Shapiro R, (1996) Characterization of mouse angiogenin-related protein: implications for functional studies on angiogenin. Proc Natl Acad Sci USA 93, 4331-4335.
34. Fu X, Roberts WG, Nobile V, Shapiro R, &, Kamps MP, (1999) mAngiogenin-3, a target gene of oncoprotein E2a-Pbx1, encodes a new angiogenic member of the angiogenin family. Growth Factors 17, 125-137.
35. Crabtree B, Holloway DE, Baker MD, Acharya KR, &, Subramanian V, (2007) Biological and structural features of murine angiogenin-4, an angiogenic protein. Biochemistry 46, 2431-2443.
36. Hooper LV, Stappenbeck TS, Hong CV, &, Gordon JI, (2003) Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 4, 269-273.
37. Forman RA, deSchoolmeester ML, Hurst RJ, Wright SH, Pemberton AD, &, Else KJ, (2012) The goblet cell is the cellular source of the anti-microbial angiogenin 4 in the large intestine post Trichuris muris infection. PLoS ONE 7, e42248-e42254.
38. Holloway DE, Chavali GB, Hares MC, Subramanian V, &, Acharya KR, (2005) Structure of murine angiogenin: features of the substrate- and cell-binding regions and prospects for inhibitor-binding studies. Acta Crystallogr D Biol Crystallogr 61, 1568-1578.
39. Ramachandran GN, Ramakrishnan C, &, Sasisekharan V, (1963) Stereochemistry of polypeptide chain configurations. J Mol Biol 7, 95-99.
40. Lo Conte L, Chothia C, &, Janin J, (1999) The atomic structure of protein-protein recognition sites. J Mol Biol 285, 2177-2198.
41. Balakrishnan R, Ramasubbu N, Varughese KI, &, Parthasarathy R, (1997) Crystal structures of the copper and nickel complexes of RNase A: metal-induced interprotein interactions and identification of a novel copper binding motif. Proc Natl Acad Sci USA 94, 9620-9625.
42. Raines RT, (1998) Ribonuclease A. Chem Rev 98, 1045-1066.
43. Lequin O, Thuring H, Robin M, &, Lallemand JY, (1997) Three-dimensional solution structure of human angiogenin determined by 1H,15N-NMR spectroscopy-characterization of histidine protonation states and pKa values. Eur J Biochem 250, 712-726.
44. Martin PD, Doscher MS, &, Edwards BF, (1987) The refined crystal structure of a fully active semisynthetic ribonuclease at 1.8-Å resolution. J Biol Chem 262, 15930-15938.
45. Kim EE, Varadarajan R, Wyckoff HW, &, Richards FM, (1992) Refinement of the crystal structure of ribonuclease S. Comparison with and between the various ribonuclease A structures. Biochemistry 31, 12304-12314.
46. Richards FM, Wyckoff HW, &, Allewell N, (1970) The origin of specificity in binding: a detailed example in a protein-nucleic acid interaction. In The Neurosciences: Second Study Program (Schmitt FO, ed), pp. 901-912. Rockefeller University Press, New York.
47. Wlodawer A, &, Sjölin L, (1983) Structure of ribonuclease A: results of joint neutron and X-ray refinement at 2.0-Å resolution. Biochemistry 22, 2720-2728.
48. delCardayré SB, &, Raines RT, (1995) A residue to residue hydrogen bond mediates the nucleotide specificity of ribonuclease A. J Mol Biol 252, 328-336.
49. Leonidas DD, Shapiro R, Allen SC, Subbarao GV, Veluraja K, &, Acharya KR, (1999) Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth. J Mol Biol 285, 1209-1233.
50. Leonidas DD, Shapiro R, Subbarao GV, Russo A, &, Acharya KR, (2002) Crystallographic studies on the role of the C-terminal segment of human angiogenin in defining enzymatic potency. Biochemistry 41, 2552-2562.
51. Zegers I, Maes D, Dao-Thi MH, Poortmans F, Palmer R, &, Wyns L, (1994) The structures of RNase A complexed with 3′-CMP and d(CpA): active site conformation and conserved water molecules. Protein Sci 3, 2322-2339.
52. Moroianu J, &, Riordan JF, (1994) Identification of the nucleolar targeting signal of human angiogenin. Biochem Biophys Res Commun 203, 1765-1772.
53. Jans DA, Xiao CY, &, Lam MH, (2000) Nuclear targeting signal recognition: a key control point in nuclear transport? BioEssays 22, 532-544.
54. Hallahan TW, Shapiro R, &, Vallee BL, (1991) Dual site model for the organogenic activity of angiogenin. Proc Natl Acad Sci USA 88, 2222-2226.
55. Hallahan TW, Shapiro R, Strydom DJ, &, Vallee BL, (1992) Importance of asparagine-61 and asparagine-109 to the angiogenic activity of human angiogenin. Biochemistry 31, 8022-8029.
56. Lee FS, &, Vallee BL, (1989) Characterization of ribonucleolytic activity of angiogenin towards tRNA. Biochem Biophys Res Commun 161, 121-126.
57. Badet J, Soncin F, Guitton JD, Lamare O, Cartwright T, &, Barritault D, (1989) Specific binding of angiogenin to calf pulmonary artery endothelial cells. Proc Natl Acad Sci USA 86, 8427-8431.
58. Soncin F, Guitton JD, Cartwright T, &, Badet J, (1997) Interaction of human angiogenin with copper modulates angiogenin binding to endothelial cells. Biochem Biophys Res Commun 236, 604-610.
59. Russo N, Acharya KR, Vallee BL, &, Shapiro R, (1996) A combined kinetic and modeling study of the catalytic center subsites of human angiogenin. Proc Natl Acad Sci USA 93, 804-808.
60. Soncin F, Strydom DJ, &, Shapiro R, (1997) Interaction of heparin with human angiogenin. J Biol Chem 272, 9818-9824.
61. Harper JW, &, Vallee BL, (1988) Conformational characterization of human angiogenin by limited proteolysis. J Protein Chem 7, 355-363.
62. Shapiro R, &, Vallee BL, (1992) Identification of functional arginines in human angiogenin by site-directed mutagenesis. Biochemistry 31, 12477-12485.
63. Holloway DE, Hares MC, Shapiro R, Subramanian V, &, Acharya KR, (2001) High-level expression of three members of the murine angiogenin family in Escherichia coli and purification of the recombinant proteins. Protein Expr Purif 22, 307-317.
64. Pace CN, Vajdos F, Fee L, Grimsley G, &, Gray T, (1995) How to measure and predict the molar absorption coefficient of a protein. Protein Sci 4, 2411-2423.
65. Shapiro R, Riordan JF, &, Vallee BL, (1986) Characteristic ribonucleolytic activity of human angiogenin. Biochemistry 25, 3527-3532.
66. Shapiro R, Weremowicz S, Riordan JF, &, Vallee BL, (1987) Ribonucleolytic activity of angiogenin: essential histidine, lysine, and arginine residues. Proc Natl Acad Sci USA 84, 8783-8787.
67. Otwinowski Z, &, Minor W, (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276, 307-326.
68. Minor W, Tomchick D, &, Otwinowski Z, (2000) Strategies for macromolecular synchrotron crystallography. Structure 8, R105-R110.
69. Navaza J, (1994) AMoRe: an automated package for molecular replacement. Acta Crystallogr 50, 157-163.
70. Emsley P, &, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126-2132.
71. Murshudov GN, Vagin AA, &, Dodson EJ, (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53, 240-255.
72. Brünger AT, (1992) Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472-475.
73. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, Wang X, Murray LW, Arendall WB III, Snoeyink J, Richardson JS, et al,. (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35, W375-W383.
74. Thompson JD, Gibson TJ, &, Higgins DG, (2002) Multiple sequence alignment using ClustalW and ClustalX. Curr Protoc Bioinformatics Chapter 2, 2.3.1-2.3.22. doi: 10.1002/0471250953.bi0203s00.
75. Bond CS, &, Schuttelkopf AW, (2009) ALINE: a WYSIWYG protein-sequence alignment editor for publication-quality alignments. Acta Crystallogr D Biol Crystallogr 65, 510-512.
76. Ladner JE, Wladkowski BD, Svensson LA, Sjölin L, &, Gilliland GL, (1997) X-ray structure of a ribonuclease A-uridine vanadate complex at 1.3 Å resolution. Acta Crystallogr D Biol Crystallogr 53, 290-301.
77. McDonald IK, &, Thornton JM, (1994) Satisfying hydrogen bonding potential in proteins. J Mol Biol 238, 777-793.
78. Bailey S, (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50, 760-763.